Protocol for TB Lab Management Review Meetings with Agenda Templates

Management review meetings sit at the heart of any functioning quality management system, and tuberculosis laboratories are no exception. Across Australian pathology networks, these structured gatherings give laboratory leaders a regular opportunity to step back from the daily bench workload and examine whether systems for sample processing, biosafety, reporting, and staff competency are delivering consistent results. A well-designed protocol, paired with a reusable agenda template, turns what can drift into an informal catch-up into a disciplined forum that drives continual improvement and supports accreditation under frameworks such as NATA and ISO 15189.

For TB laboratories in Australia, where teams often span metro hubs like Sydney, Melbourne, and Brisbane alongside regional and remote sites, the meeting itself can become a logistical puzzle. Time zones shift by two hours from Perth to the eastern states, sample referral chains cross state borders, and reference functions housed at the state Mycobacterium reference laboratories in Adelaide and Perth must be coordinated with busy diagnostic benches. A written protocol sets the ground rules so that whether participants dial in from a hospital laboratory in western Sydney or a remote clinic servicing a First Nations community in the Northern Territory, the meeting produces usable outputs.

Defining Purpose and Scope of the Review

Before drafting any agenda, the laboratory needs to agree on what the management review is meant to achieve. In a TB setting this usually means confirming that smear microscopy, culture, and molecular workflows such as Xpert MTB/RIF Ultra or line-probe assays are performing within expected quality limits, that biosafety cabinets and biological safety practices remain compliant, and that turnaround times for both routine and priority specimens are being met. The purpose statement should also call out how the review feeds into the broader Quality Systems Essentials outlined by the GLI roadmap, including equipment calibration, internal audits, and supplier management.

Scope should explicitly mention which sites, sections, and external partners are included. A multi-site network operating across Queensland and Victoria, for instance, will want to clarify whether the meeting covers the entire chain or only specific nodes. Including external stakeholders such as the state Tuberculosis Control Program or the National Tuberculosis Advisory Committee as observers or agenda contributors can sharpen the discussion, particularly when policy changes from the Therapeutic Goods Administration or state Public Health Acts have shifted reporting requirements.

Setting the Cadence, Attendees, and Quorum

Most Australian TB laboratories settle on quarterly reviews, with some opting for monthly executive sessions focused on operational KPIs. Whatever the cadence, it must be realistic for staff who already manage heavy bench rotations, and it should align with the audit schedule leading toward re-accreditation. For laboratories applying for or maintaining NATA accreditation, scheduling the management review to precede the external assessment gives the team a chance to address findings before assessors arrive.

The attendee list should include the laboratory director or delegate, the quality manager, section heads for microscopy, culture, and molecular diagnostics, a biosafety officer, and a representative from administration or data management. When meetings are held virtually, an attendance log capturing dial-in locations provides useful evidence of organisational reach. A quorum rule, typically the laboratory director plus at least half of section heads, ensures decisions carry authority and prevents meetings from collapsing into inconclusive discussion.

Structuring the Agenda Template

A reliable agenda template begins with administrative housekeeping: confirmation of the previous minutes, declaration of conflicts of interest, and acceptance of the agenda. From there, it should move through standing items that mirror the Quality Systems Essentials. Suggested blocks include a review of quality indicators and turnaround time trends, internal and external audit outcomes, corrective and preventive actions, supplier and equipment performance, customer feedback including complaints from clinicians and patients, and a forward look at risks and opportunities.

Time allocations matter. A 90-minute slot works for many Australian TB laboratories, with roughly 15 minutes reserved at the end for action item confirmation. Sections that tend to overrun, such as reviewing non-conformities linked to sample contamination or power interruptions in remote sites, should be flagged with a clear cut-off time. Embedding prompts within the template keeps discussions evidence-based rather than anecdotal.

A practical resource for identifying workflow inefficiencies ahead of the meeting is a structured time motion study conducted in the weeks before the review. Feeding that data into the agenda transforms the meeting from a status update into a forum where concrete bottlenecks can be addressed with agreed actions.

Preparing the Documentation Pack

A management review is only as strong as the paperwork supporting it. Participants should receive a pack at least five working days in advance, giving them time to read rather than skim. Typical contents include the previous minutes with action status, a KPI dashboard covering turnaround times, contamination rates, and EQA performance for the relevant TB testing panels, an audit summary, and any updated risk registers. For laboratories operating across multiple Australian states, a one-page state-by-state summary highlights variation and helps meeting participants from different jurisdictions stay oriented.

Distribution can be handled through the laboratory's document control system, with version numbers and access logs recorded for accreditation evidence. Care should be taken to redact patient identifiers and to comply with the Privacy Act when sharing data from external sites. Including a cover sheet that lists the pack contents, the meeting date, and the expected outcomes gives the document a clear audit trail.

Running the Meeting and Recording Decisions

On the day, the chair should open with a reminder of the meeting's purpose, recap the quorum, and confirm the time allocated for each agenda item. Minutes need to capture the topic discussed, the decision taken, the person responsible, and the due date — this four-field format is widely accepted across Australian pathology services and feeds directly into corrective action tracking. Decisions about resources, such as approving the purchase of a new MGIT system or additional biosafety cabinet certification, should reference the budget cycle so that follow-through is realistic.

Recording is straightforward: a designated minute-taker captures the discussion in real time while the chair keeps momentum. For laboratories that have begun adopting digital minute-taking tools, exporting minutes into the document control system within 48 hours keeps the action register current. The chair should also note any items deferred to the next meeting, with a clear reason, so that nothing quietly slips off the agenda.

Following Up Between Reviews

The protocol does not stop when the meeting closes. Each action item should be entered into the laboratory's quality register with a unique identifier, a responsible owner, and a review date. A short mid-cycle check-in, often by email or a 15-minute teleconference between quarterly reviews, helps owners report progress and flags items at risk of slipping. This is particularly useful for actions that depend on suppliers, such as pending equipment validations, or on external bodies like state health departments reviewing changes to TB notification forms under local Public Health legislation.

Laboratories working across remote regions, including services supporting Aboriginal and Torres Strait Islander communities, may find that some corrective actions require longer lead times because of supply chain distances and the need for cultural safety briefings before service changes. The follow-up framework should accommodate these realities rather than treat them as exceptions.

Reviewing the Protocol Annually

Like any quality document, the management review protocol itself should be reviewed at least once a year. Feedback from participants about agenda length, time of day, and whether the meeting produced actionable outcomes is valuable input. Many Australian laboratories invite an external observer, perhaps a colleague from a neighbouring network or a representative from a state reference laboratory, to provide candid feedback on meeting conduct and documentation quality.

For teams seeking a tested framework to anchor their own management review process, the GLI Quality Tool offers phase-aligned guidance, checklists, and downloadable templates that can be adapted to local context. Pairing those resources with a disciplined internal protocol gives TB laboratories a sturdy platform for sustained quality improvement.

If your TB laboratory is ready to formalise its management review process, start by drafting a one-page protocol using the sections above, pilot it at the next scheduled meeting, and refine it based on participant feedback. Share the resulting template across your network so that every site — from the largest tertiary referral hospital to the smallest remote clinic — speaks a shared quality language and contributes to stronger TB control across Australia.